These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 29122667

  • 1. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
    Baltzer PAT, Bennani-Baiti B, Stöttinger A, Bumberger A, Kapetas P, Clauser P.
    Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [Abstract] [Full Text] [Related]

  • 3. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    Bennani-Baiti B, Dietzel M, Baltzer PA.
    PLoS One; 2017 Mar; 12(11):e0188679. PubMed ID: 29190656
    [Abstract] [Full Text] [Related]

  • 4. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.
    Hrkac Pustahija A, Ivanac G, Brkljacic B.
    Diagn Interv Radiol; 2018 Jul; 24(4):187-194. PubMed ID: 30091708
    [Abstract] [Full Text] [Related]

  • 5. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing?
    Shimauchi A, Machida Y, Maeda I, Fukuma E, Hoshi K, Tozaki M.
    Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685
    [Abstract] [Full Text] [Related]

  • 6. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.
    Li S, Lin Y, Liu G, Shao Z, Yang Y.
    Breast Cancer Res Treat; 2024 Jul; 206(2):425-435. PubMed ID: 38664289
    [Abstract] [Full Text] [Related]

  • 7. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
    Wengert GJ, Pipan F, Almohanna J, Bickel H, Polanec S, Kapetas P, Clauser P, Pinker K, Helbich TH, Baltzer PAT.
    Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
    [Abstract] [Full Text] [Related]

  • 8. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.
    Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, Sardanelli F, Giuseppetti GM, Simonetti G, Lattanzio V, Del Maschio A.
    AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666
    [Abstract] [Full Text] [Related]

  • 9. Bayesian network to predict breast cancer risk of mammographic microcalcifications and reduce number of benign biopsy results: initial experience.
    Burnside ES, Rubin DL, Fine JP, Shachter RD, Sisney GA, Leung WK.
    Radiology; 2006 Sep; 240(3):666-73. PubMed ID: 16926323
    [Abstract] [Full Text] [Related]

  • 10. Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis.
    Fueger BJ, Clauser P, Kapetas P, Pötsch N, Helbich TH, Baltzer PAT.
    Breast; 2021 Apr; 56():53-60. PubMed ID: 33618160
    [Abstract] [Full Text] [Related]

  • 11. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM, Piato S, Roveda D, de Faria Castro Fleury E.
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [Abstract] [Full Text] [Related]

  • 12. The value of MRI contrast enhancement in biopsy decision of suspicious mammographic microcalcifications: a prospective multicenter study.
    Taskin F, Kalayci CB, Tuncbilek N, Soydemir E, Kurt N, Kaya H, Aribal E.
    Eur Radiol; 2021 Mar; 31(3):1718-1726. PubMed ID: 32939619
    [Abstract] [Full Text] [Related]

  • 13. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
    Linda A, Zuiani C, Londero V, Di Gaetano E, Dal Col A, Girometti R, Bazzocchi M.
    Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
    [Abstract] [Full Text] [Related]

  • 14. MRI and comparison mammography: a worthy diagnostic alliance for breast microcalcifications?
    Brnic D, Brnic D, Simundic I, Vanjaka Rogosic L, Tadic T.
    Acta Radiol; 2016 Apr; 57(4):413-21. PubMed ID: 25995311
    [Abstract] [Full Text] [Related]

  • 15. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS, Lee SM, Cha ES.
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [Abstract] [Full Text] [Related]

  • 16. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T, Yuen S, Kasami M, Uchida Y.
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [Abstract] [Full Text] [Related]

  • 17. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].
    Michel SC, Löw R, Singer G, Otto R, Hohl M, Kubik RA.
    Praxis (Bern 1994); 2007 Sep 26; 96(39):1459-74. PubMed ID: 17966279
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A risk stratification algorithm for lesions of uncertain malignant potential diagnosed by vacuum-assisted breast biopsy (VABB) of mammographic microcalcifications.
    Clauser P, Kapetas P, Stöttinger A, Bumberger A, Rudas M, Baltzer PAT.
    Eur J Radiol; 2021 Feb 26; 135():109479. PubMed ID: 33370641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.